bpi labs semaglutide Thurs news: Employers drop GLP-1 weight loss drug coverage as use surges. J&J adds rare disease wAIHA to Imaavy's potential uses. Takeda's $4B TYK2 drug tops Bristol Myers' Sotyktu in head-to-head. Novartis Reassure me my med is

GLP-1 agonists can be a powerful tool to manage diabetes and control weight, but like any medication, theyre not without risks, so talking with your doctor is always a good choice.

T2DM, a chronic and widespread worldwide disease, is characterized by insulin resistance, hyperglycemia, oxidative stress, neuroinflammation, and cerebrovascular dysfunction, factors that collectively contribute to cognitive decline

Going higher has not been studied for safety or efficacy

Hunting for heroes: Brain neurons mediating GLP-1R agonists in obesity treatment

Animal studies, such as those summarized in a review on GLP1RA use in pregnancy, show concerning outcomes including fetal growth restriction and skeletal malformations

Use the middle third of the outer thigh